In June 2019, the US Food and Drug Administration approved the Nucleus® Profile™ Plus Implant that can now allow for easier access to 1.5 and 3.0 Tesla (T) MRI scans without the need to remove the internal magnet or wear a head wrap.1 The Nucleus Profile Plus Implant is built on Cochlear's unrivaled cochlear implant reliability record of the Profile Implant and the entire Cochlear Nuchleus implant portfolio.2-4
The FDA also approved direct streaming from Android phones* to the Nucleus 7 Sound Processor without intermediary devices or attachments.** This update follows the 2017 innovation of the Nucleus 7 Sound Processor being “the world’s first Made for iPhone cochlear implant sound processor”.5 The Nucleus 7 Sound Processor’s expanded connectivity features for Android will be commercially available this fall across the U.S. and Canada through a simple firmware update.
For more information on these FDA approvals, visit Cochlear.com
To learn more about diagnosis and treatment with a Cochlear hearing solution, visit https://www.cochlear.com/us/en/home/diagnosis-and-treatment
* For complete smartphone compatibility information, please visit www.cochlear.com/compatibility.
**Access is dependent upon Android phone manufacturers implementing Google’s Audio Streaming for Hearing Aids (ASHA) protocol into future operating system updates for handsets.
2 Cochlear Nucleus Implant Reliability Report. Volume 17 | December 2018. D1593476. Cochlear Ltd; 2019.
3 Hearing Implant Reliability Reporting | MED-EL [Internet]. Medel.com. 2018 [cited 06May2019]. Available from: https://www.medel.com/us/reliabilityreporting
4 2018 Global Implant Reliability Report. 027-N025-02. Advanced Bionics AG and affiliates.; 2019.i
5 Cochlear introduces the world's first Made for iPhone cochlear implant sound processor | July 2017. Available from: https://www.cochlear.com/intl/about/media-centre/cochlear-introduces-the-worlds-first-made-for-iphone-cochlear-implant-sound-processor
The Hearing Industries Association is the trusted voice on hearing health care for product innovation, public policy, patient safety and education.
